These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 32691991

  • 21. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
    Long J, Pi X.
    Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
    [Abstract] [Full Text] [Related]

  • 22. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
    Ge JC, Wang YX, Chen ZB, Chen DF.
    Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
    [Abstract] [Full Text] [Related]

  • 23. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
    Tahtouh R, Azzi AS, Alaaeddine N, Chamat S, Bouharoun-Tayoun H, Wardi L, Raad I, Sarkis R, Antoun NA, Hilal G.
    PLoS One; 2015 Feb; 10(3):e0119512. PubMed ID: 25822740
    [Abstract] [Full Text] [Related]

  • 24. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
    Abusaliya A, Bhosale PB, Kim HH, Park MY, Jeong SH, Lee S, Kim GS.
    Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
    [Abstract] [Full Text] [Related]

  • 25. Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation.
    You P, Wu H, Deng M, Peng J, Li F, Yang Y.
    Biomed Pharmacother; 2018 Feb; 98():619-625. PubMed ID: 29289836
    [Abstract] [Full Text] [Related]

  • 26. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
    Wei H, Hu J, Pu J, Tang Q, Li W, Ma R, Xu Z, Tan C, Yao T, Wu X, Long X, Wang J.
    Int Immunopharmacol; 2019 Aug; 73():72-80. PubMed ID: 31082725
    [Abstract] [Full Text] [Related]

  • 27. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Ye R, Dai N, He Q, Guo P, Xiang Y, Zhang Q, Hong Z, Zhang Q.
    Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391
    [Abstract] [Full Text] [Related]

  • 28. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
    Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH, Xu J, Hu HG, Qiu L, Li JZ, He ZG, Zhang JP.
    Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936
    [Abstract] [Full Text] [Related]

  • 29. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M.
    Molecules; 2019 Jan 22; 24(3):. PubMed ID: 30678274
    [Abstract] [Full Text] [Related]

  • 30. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Chen XL, Fu JP, Shi J, Wan P, Cao H, Tang ZM.
    Mol Med Rep; 2015 Dec 22; 12(6):8229-36. PubMed ID: 26496900
    [Abstract] [Full Text] [Related]

  • 31. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
    Chen S, Yao L.
    Cancer Chemother Pharmacol; 2021 Aug 22; 88(2):323-334. PubMed ID: 33978839
    [Abstract] [Full Text] [Related]

  • 32. AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.
    Zhu G, Luo L, He Y, Xiao Y, Cai Z, Tong W, Deng W, Xie J, Zhong Y, Hu Z, Shan R.
    Mol Carcinog; 2024 Sep 22; 63(9):1814-1826. PubMed ID: 38874176
    [Abstract] [Full Text] [Related]

  • 33. LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway.
    Pu Z, Wu L, Guo Y, Li G, Xiang M, Liu L, Zhan H, Zhou X, Tan H.
    J Cell Biochem; 2019 Oct 22; 120(10):18172-18185. PubMed ID: 31144362
    [Abstract] [Full Text] [Related]

  • 34. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G, Liu X, Li H, Yan Y, Hong X, Lin Z.
    Int J Immunopathol Pharmacol; 2018 Oct 22; 32():2058738418814341. PubMed ID: 30477356
    [Abstract] [Full Text] [Related]

  • 35. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL.
    Mol Cancer Ther; 2016 Nov 22; 15(11):2553-2562. PubMed ID: 27496136
    [Abstract] [Full Text] [Related]

  • 36. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

  • 37. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells.
    Gong L, Di C, Xia X, Wang J, Chen G, Shi J, Chen P, Xu H, Zhang W.
    Int J Oncol; 2016 Dec 24; 49(6):2538-2548. PubMed ID: 27779641
    [Abstract] [Full Text] [Related]

  • 38. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo.
    Wang S, Zhang C, Li Y, Li P, Zhang D, Li C.
    Cancer Chemother Pharmacol; 2019 Mar 24; 83(3):519-530. PubMed ID: 30542770
    [Abstract] [Full Text] [Related]

  • 39. Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin.
    Qin B, Zeng Z, Xu J, Shangwen J, Ye ZJ, Wang S, Wu Y, Peng G, Wang Q, Gu W, Tang Y.
    BMC Cancer; 2022 Jun 18; 22(1):671. PubMed ID: 35715752
    [Abstract] [Full Text] [Related]

  • 40. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N, Ewald F, Hofmann BT, Staufer K, Schumacher U, Nashan B, Jücker M.
    Mol Cancer; 2012 Nov 20; 11():85. PubMed ID: 23167739
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.